We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-2.16%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$410M
AUM Growth
+$95.1M
Cap. Flow
+$111M
Cap. Flow %
27.15%
Top 10 Hldgs %
61.88%
Holding
29
New
2
Increased
18
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$13.5M
2
CANO
Cano Health, Inc.
CANO
+$13.4M
3
UTHR icon
United Therapeutics
UTHR
+$10.9M
4
AMWL icon
American Well
AMWL
+$10.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$10.2M

Top Sells

Rank Stock Value
1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$8.2M
2
DXCM icon
DexCom
DXCM
+$1.61M
3
OM icon
Outset Medical
OM
+$188K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCCC icon
26
C4 Therapeutics
CCCC
$428M
$1.52M 0.37%
47,200
– –
LYEL icon
27
Lyell Immunopharma
LYEL
$365M
$774K 0.19%
5,000
– –
OLK
28
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$728K 0.18%
40,000
– –
DRNA
29
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-406,525
Closed -$8.2M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Eagle Health Investments held 29 positions worth $410M, up 30% from $315M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eagle Health Investments deployed $111M of net new capital in Q4 2021, opening 2 new positions and adding to 18 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 80,500 shares worth $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier.

On the sell side, the largest reduction was DexCom, an estimated $1.61M trimmed.

  • Eagle Health Investments's largest Q4 2021 buy was Seagen Inc. Common Stock: 80,500 shares worth $12.4M.
  • Eagle Health Investments added most to Cano Health, Inc. in Q4 2021, an estimated $13.4M increase.
  • Eagle Health Investments's biggest Q4 2021 reduction was DexCom, cutting an estimated $1.61M.
  • Eagle Health Investments fully exited Dicerna Pharmaceuticals, Inc. in Q4 2021, selling an estimated $8.2M.
  • Eagle Health Investments's ten largest holdings make up 62% of its $410M portfolio in Q4 2021.
  • Eagle Health Investments opened 2 new positions and closed 1 in Q4 2021.
  • Eagle Health Investments's portfolio value rose 30% quarter-over-quarter to $410M.

Based on Eagle Health Investments's 13F filing for Q4 2021, filed 10 Feb 2022.